Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Drug Development

Oxford researchers working on drug development for COVID-19

Ivan Ahel

Sir William Dunn School of Pathology

Phil Biggin

Department of Biochemistry

Sarah Blagden

Department of Oncology

Lynne Cox

Department of Biochemistry

Susie Dunachie

Centre for Tropical Medicine & Global Health (NDM)

Ervin Fodor

Sir William Dunn School of Pathology

Jonathan Grimes

Nuffield Department of Medicine (NDM)

Geoffrey Higgins

Department of Oncology

Ling-Pei Ho

Nuffield Department of Medicine (NDM)

Richard Hobbs

Nuffield Department of Primary Care Health Sciences (PHC)

Peter Horby

Centre for Tropical Medicine & Global Health (NDM)

Stephen Hyde

Nuffield Division of Clinical Laboratory Sciences (RDM)

E.Yvonne Jones

Nuffield Department of Medicine (NDM)

Paul Klenerman

Nuffield Department of Medicine (NDM)

Giorgio Napolitani

Radcliffe Department of Medicine (RDM)

Ray Owens

Structural Biology (NDM)

Christina Redfield

Department of Biochemistry

Sumana Sanyal

Sir William Dunn School of Pathology

Quentin Sattentau

Sir William Dunn School of Pathology

Peter Simmonds

Nuffield Department of Medicine (NDM)

Michael Skwarski

Department of Oncology

David Stuart

The Jenner Institute / Structural Biology (NDM)

John Todd

Wellcome Trust Centre for Human Genetics (NDM)

Alain Townsend

MRC Weatherall Institute of Molecular Medicine (RDM)

Load More